Product introduction
Sorafenat Tablet belongs to the class of medicines known as tyrosine kinase inhibitors used in the treatment of liver cancer, kidney cancer, and thyroid cancer.
Sorafenat Tablet should be taken on an empty stomach, but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Fatigue, nausea, loss of appetite, hair loss and diarrhea are some common side effects of this medicine. It might cause high blood pressure, so the doctor may ask you for a regular check-up of blood pressure. You must inform your doctor if you notice severe skin reaction such as skin rash, or any pain, swelling, and redness of your hands and feet.
Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or high blood pressure. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
Uses of Sorafenat Tablet
- Thyroid cancer
- Kidney cancer
- Liver cancer
Benefits of Sorafenat Tablet
In Thyroid cancer
Side effects of Sorafenat Tablet
Common side effects of Sorafenat
- Fatigue
- Nausea
- Loss of appetite
- Diarrhea
- Abdominal pain
- Hair loss
- Weight loss
- Rash
- Painful blisters on hands and feet
How to use Sorafenat Tablet
How Sorafenat Tablet works
Safety advice

Alcohol

Pregnancy

Breast feeding

Driving

Kidney
Regular monitoring of blood tests may be advised while you are taking this medicine.

Liver
What if you forget to take Sorafenat Tablet?
Quick tips
- Sorafenat Tablet is used in the treatment of liver, kidney, and thyroid cancer.
- Take it without food, or with a low fat meal and a full glass of water.
- Take it at the same time everyday to maintain consistent levels in your body.
- Women who could get pregnant should use a reliable method of contraception to prevent pregnancy while taking this medicine.
- Your doctor may regularly monitor your blood pressure while you are taking this medicine.
- Inform your doctor if you get a skin rash, or any pain, swelling, and redness of your hands and feet while you are taking this medicine.
- Do not change the dose or discontinue use without consulting your doctor.
FAQs
How is Sorafenat Tablet administered?
For how long do I need to take Sorafenat Tablet?
Do I need to take a treatment along with Sorafenat Tablet for it to work?
How do I know if I am responding to Sorafenat Tablet?
What are the serious side effects that can occur while taking Sorafenat Tablet?
Does Sorafenat Tablet affect blood sugar levels?
I have developed redness and pain in my palms and soles ever since I started using Sorafenat Tablet. My skin is also coming off. Is this dangerous? What should I do?
References:-
-
FDA (DailyMed) — Sorafenib Tablets Fresh Prescribing Information
Comprehensive, FDA-approved prescribing details for sorafenib 200 mg tablets.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b7919013-1511-44f0-a759-3fa78a9fa178 DailyMed -
FDA — ANDA Approval Letter for Mylan’s Generic Sorafenib (200 mg)
Official FDA correspondence detailing approval and 180-day exclusivity for the generic sorafenib by Mylan (Natco’s partner).
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/207012Orig1s000ltr.pdf FDA Access Data -
PharmaAdvancement — Natco Pharma Receives USFDA Tentative Approval
Industry notice confirming that Natco Pharma (via partner Mylan) secured tentative ANDA approval for sorafenib 200 mg.
https://www.pharmaadvancement.com/drug-development/fda-approvals/natco-pharma-limited-receives-usfda-tentative-approval-for-sorafenib-tablets-200mg/ Pharma Advancement -
Business Standard — Filing for FDA ANDA with Paragraph IV Certification
Reports Natco Pharma and Mylan filing an ANDA with a Paragraph IV envelope for sorafenib 200 mg, potentially earning marketing exclusivity.
https://www.business-standard.com/article/companies/natco-pharma-s-partner-mylan-files-application-for-sorafenib-with-the-usfda-115021101267_1.html Business Standard -
Indian Pharma Post — Natco Launches First Generic Nexavar (Sorafenib) Tablets in U.S.
News on Natco’s launch of the first generic version of Nexavar (sorafenib) 200 mg tablets in the U.S., via partner Viatris.
https://www.indianpharmapost.com/news/natco-launches-first-generic-version-of-nexavar-tablets-in-the-us-12389
Reviews
There are no reviews yet.